# Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma

> **NCT00115193** · PHASE2 · COMPLETED · sponsor: **Amgen** · enrollment: 77 (actual)

## Conditions studied

- Non-Hodgkin's Lymphoma

## Interventions

- **DRUG:** pegfilgrastim
- **DRUG:** pegfilgrastim

## Key facts

- **NCT ID:** NCT00115193
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2013-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00115193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00115193, "Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00115193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*